Brello Health Review

Brello Health at a glance: a no-frills compounded GLP-1 platform

Brello Health is a straightforward telehealth wellness service built around one job: getting compounded semaglutide or tirzepatide into the hands of people who want to start a GLP-1 program without a lot of ceremony. There's no oral pill option, no brand-name Wegovy or Zepbound on the shelf, and no elaborate coaching apparatus. What you get is a provider health review, the medication if you're approved, the syringes and needles to inject it, and a library of virtual fitness and nutrition classes. If that bare-bones, medication-first setup is what you're after, Brello is a reasonable mainstream option. If you want hand-holding or transparent pricing before you commit, it's a harder sell.

What Brello actually ships you

Brello deals only in compounded GLP-1s — these are pharmacy-mixed versions of semaglutide and tirzepatide, not the FDA-approved branded injectables. That's worth understanding up front, because compounded drugs aren't reviewed by the FDA for safety or effectiveness the same way Wegovy, Ozempic, or Zepbound are. Brello does disclose the compounded nature of its medication on its own site, which is the honest thing to do, but it's on you to be comfortable with that trade-off. The upside of compounded is usually cost and availability; the downside is the lighter regulatory backing.

Each program includes the pieces you need to actually self-inject at home:

• A provider health review to determine whether you're approved for treatment
• Your compounded medication — semaglutide or tirzepatide — if the provider signs off
• Syringes with needles included, so you're not sourcing supplies separately
• Access to virtual fitness and nutrition classes

One honest caveat on that last item: the classes are group-style virtual sessions, not one-on-one coaching. If you were hoping for a dedicated dietitian or a personal check-in cadence, set your expectations accordingly. Brello gives you educational content, not a personal coach.

The pricing question — and why we can't post a number

This is Brello's biggest weak spot in our review. The provider does not publish a stable, verified standard rate in our record, so we won't quote a hard monthly figure here. What we can tell you is the structure: Brello runs on a multi-month commitment rather than a true month-to-month plan, so the real cost of trying it is several months of medication, not a single low intro charge — and there's no verified first-month teaser rate on file. For context, the typical compounded GLP-1 program across the providers we track lands around $169 a month, and Brello has at times appeared to price below the branded alternatives, which can run well over a thousand dollars a month. But because it asks for a multi-month minimum, this isn't a platform to 'dip a toe' into: confirm the total cost of the full commitment, not just one month, directly with Brello before you hand over a card.

Where you can — and can't — get it

Brello ships to 34 states plus Washington, D.C., which puts it in solidly mainstream coverage territory but not nationwide. The notable gaps include California, Washington, Nevada, Michigan, Indiana, West Virginia, North Carolina, South Carolina, Arkansas, Alabama, Tennessee, Hawaii, Massachusetts, Connecticut, New Jersey, and Maryland. That's a meaningful list — if you're in a big state like California, you're out of luck for now. Brello's own site says it's 'coming to more states soon,' so the map may widen, but don't count on access until it's actually live where you are.

Who Brello is right for — and who should skip it

Brello fits a specific kind of patient: someone who already knows they want a compounded GLP-1, is comfortable self-injecting, doesn't need intensive coaching, and lives in one of its covered states. For that person, the medication-plus-supplies-plus-classes bundle is clean and uncomplicated, and having both semaglutide and tirzepatide on the menu means you and your provider have a real choice of molecule.

You should probably skip Brello if any of these apply:

• You want brand-name Wegovy, Ozempic, or Zepbound — Brello only offers compounded versions
• You need pricing certainty before committing — Brello doesn't publish a verified standard rate
• You want one-on-one coaching or a dedicated dietitian — the classes are group-style only
• You prefer an oral GLP-1 — Brello is injection-only
• You live in California, Washington, New Jersey, or one of the other excluded states

Trust, safety, and what we could verify

On the reassuring side, there are no FDA warning letters or enforcement actions on file against Brello in our records, and the platform is upfront about the fact that it dispenses compounded medication rather than dressing it up as branded product. A provider health review gates access to treatment, so you're not simply buying a drug off a shelf. On the cautious side, our verification is thinner than we'd like: Brello does not disclose its specific compounding pharmacy partner or accreditation details to us, and its pricing isn't transparently published. That combination — real medical gating but limited supply-chain and price transparency — is why we'd put Brello in the 'fine for mainstream access, but verify the details yourself' category rather than at the top of the class. You can read how we weigh these factors in our scoring methodology.

Bottom line

Brello Health does the core job competently: it offers both compounded semaglutide and tirzepatide, includes the injection supplies, throws in virtual fitness and nutrition classes, and covers 34 states plus D.C. It's an unfussy way to start a GLP-1 program if you're an informed, self-directed patient. The reasons to pause are equally clear — no published standard price, a multi-month commitment, group-only classes, compounded-only medication, and undisclosed pharmacy accreditation. If you go in, do two things first: confirm the exact current price and total commitment cost directly with Brello, and make sure you're genuinely comfortable with compounded GLP-1s. Do that, and Brello is a serviceable mainstream pick. Skip those steps, and you're signing up blind.

For a side-by-side, SkinnyRx ($149.25/month) and Midi Health ($164/month) are the most comparable options to weigh against Brello Health.